Opera Bioscience enables Biotech partners to produce high purity proteins and antibodies for therapeutic use, while also minimizing development and manufacturing timelines. By harnessing a bacterial system that can fully secrete proteins out of the cell in a single step, Opera Bioscience can ensure the creation of high-purity proteins from the outset. This approach removes the need for costly and time-consuming downstream processing steps, capitalizing instead on highly efficient continuous fermentation processes. The outcome is a protein manufacturing solution that is both cost-effective and scalable, allowing customers to expedite the launch of their biosimilars and therapeutics while keeping production costs at a minimum.
External link for Opera Bioscience
Chicago, IL, US
Opera Bioscience reposted this
The people person’s protein people. Took home the audience choice award for Opera Bioscience at ACS BIOT Tank! I got beat up in the Q&A but you learn a ton about your messaging when the judges are deep industry vets. #bears #beats #bacterialproteinsecretion #battlestargalactica
We'll be at ACS BIOT from March 23-27, and our CEO, Gerry Sapienza, will be kicking things off with a pitch at BIOT Tank on Day 1! If you're at the conference, come support us (audience gets a vote on the winner!) talk about protein production. See you there! #ACSBIOT #BIOTTank #Biomanufacturing #SynBio
We’re excited to share that Nina Dudnik, PhD is joining Opera Bioscience as our new advisor! Nina’s thoughtful perspective on building companies in Bio coupled with her own entrepreneurial experience make her a fantastic addition to our team. On top of that, we’ve clicked over everything from big ideas to a shared love of lab equipment auctions (it’s a thing!). She also just a fantastic person. We feel lucky to have her guidance as we continue growing and tackling new challenges. Welcome, Nina—we’re so glad to have you on board!
No stranger to potions, Julie Ming Liang conjured interest in protein manufacturing at Activate's demo day during the ToughTech Summit in Boston earlier this month. Not magic—just smart science. Happy Halloween! #toughtech #Activate #biomanufacturing #proteins #spooky
🚨 Big Win for Opera Bioscience 🚨 We just landed a Phase I SBIR grant from the NIH. This is an important milestone and a huge statement of support. Our tech is here to make protein production cheaper and easier, and this grant is the fuel we need to push even harder. Shoutout to the relentless crew who've put in the hard work to get us to where we are, and to the National Institute of General Medical Sciences for backing bold science. We're just getting things started—expect more breakthroughs as we're here to change-up the decades old processes holding biomanufacturing back. #SBIR #NIHGrant #BiotechInnovation #ProteinExpression #RecombinantProteins #Biotechnology #OperaBioscience #BiotechRebellion
Big welcome to our Q Summer Scholar, Andrew Chin! Andrew is joining the Opera lab for a summer internship. He’ll be working on some fermentation scale-up and testing out a whole bunch of proteins. He’s already crushing his first ever Western Blots. Great to have you on the team, Andrew!
Wrapping up this year’s BioMADE member meeting with some fantastic weather in Minneapolis. Julie Ming Liang and Gerry Sapienza got to present some of the high purity protein manufacturing results from our research at the poster session happy hour. Great conversations with industry, government, and academic representatives focusing on building up US based biomanufacturing
Couldn’t make it to Austin for SXSW? Well now you can now listen to Julie and her fellow Fellows discuss climate-related innovation on Activate’s inaugural podcast recorded during their panel at SXSW.
🎧 We’re excited to launch our new podcast, “Science on a Mission”! This podcast intends to demystify the path to commercialization for deep tech innovation. Whether you're a scientist looking to bring your discovery to market, an investor seeking the next big thing, or simply a tech enthusiast eager to stay on the cutting edge, "Science on a Mission" is your guide to the future of technology. Join us as we explore the stories, strategies, and successes that define the journey of deep tech innovation. Our first three episodes were recorded live at SXSW. In our first episode, Molly Wood, founder and CEO of Molly Wood Media, talks to Activate CEO Cyrus Wadia, Opera Bioscience Chief Science Officer and Co-founder Julie Ming Liang, and Terra Watts Co-founder and CEO Kaitlyn A. Suarez about how the urgent need for climate solutions has ignited a surge in innovation, pushing the boundaries of environmental technology and sustainability. This conversation aims to provide a comprehensive overview of the challenges and opportunities for science founders, the drivers of growth in climate tech startups, inspiring areas of innovation, and the role of investors. Listen now! Apple Podcasts: https://lnkd.in/gdP_VHSx Spotify: https://lnkd.in/gG4wSTvX YouTube: https://lnkd.in/gyza-9zk
Wouldn't miss #SynBioBeta2024 for the world. The team is once again headed to the Bay area, this time San Jose to catch up on the latest in the Synthetic Bio world as we quite literally grow the #bioeconomy for a healthier and more sustainable future. Reach out to Gerry Sapienza and Julie Ming Liang if you'll be out there too and please come find them! https://lnkd.in/epsYRT3H